Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Garcia JS, Flamand Y, Penter L, Keng M, Tomlinson BK, Mendez LM, Koller P, Cullen N, Arihara Y, Pfaff K, Wolff JO, Brunner AM, Galinsky I, Bashey A, Antin JH, Cutler C, Ho V, Jonas BA, Luskin MR, Wadleigh M, Winer ES, Savell A, Leonard R, Robertson T, Davids MS, Streicher H, Rodig SJ, Ritz J, Wu CJ, DeAngelo DJ, Neuberg D, Stone RM, Soiffer RJ. Garcia JS, et al. Among authors: flamand y. Blood. 2023 Apr 13;141(15):1884-1888. doi: 10.1182/blood.2022017686. Blood. 2023. PMID: 36332187 Free PMC article.
Reply to A.S. Garden.
Ferris RL, Burtness B, Flamand Y. Ferris RL, et al. Among authors: flamand y. J Clin Oncol. 2022 Apr 1;40(10):1133-1134. doi: 10.1200/JCO.22.00063. Epub 2022 Feb 16. J Clin Oncol. 2022. PMID: 35171688 No abstract available.
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.
Versluis J, Pandey M, Flamand Y, Haydu JE, Belizaire R, Faber M, Vedula RS, Charles A, Copson KM, Shimony S, Rozental A, Bendapudi PK, Wolach O, Griffiths EA, Thompson JE, Stone RM, DeAngelo DJ, Neuberg D, Luskin MR, Wang ES, Lindsley RC. Versluis J, et al. Among authors: flamand y. Blood Adv. 2022 May 10;6(9):2835-2846. doi: 10.1182/bloodadvances.2021006166. Blood Adv. 2022. PMID: 35081257 Free PMC article.
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Athale UH, Flamand Y, Blonquist T, Stevenson KE, Spira M, Asselin BL, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Harris MH, Neuberg DS, Sallan SE, Silverman LB. Athale UH, et al. Among authors: flamand y. Pediatr Blood Cancer. 2022 Aug;69(8):e29581. doi: 10.1002/pbc.29581. Epub 2022 Mar 22. Pediatr Blood Cancer. 2022. PMID: 35316569
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG, Flamand Y, Stevenson KE, Neuberg DS, Athale UH, Kelly KM, Laverdiere C, Michon B, Place AE, Sallan SE, Silverman LB, Vrooman LM. Welch JJG, et al. Among authors: flamand y. Pediatr Blood Cancer. 2023 Nov;70(11):e30560. doi: 10.1002/pbc.30560. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37461125 Clinical Trial.
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.
Valtis YK, Flamand Y, Shimony S, Place AE, Silverman LB, Vrooman LM, Brunner AM, Sallan SE, Wadleigh M, Stone RM, DeAngelo DJ, Luskin MR. Valtis YK, et al. Among authors: flamand y. Leukemia. 2024 Mar;38(3):482-490. doi: 10.1038/s41375-023-02115-4. Epub 2024 Jan 5. Leukemia. 2024. PMID: 38177437
PediCARE: Development of a poverty-targeted intervention for pediatric cancer.
Umaretiya PJ, Revette A, Seo A, Flamand Y, Ilcisin L, Zheng DJ, Bhatia S, Wolfe J, Bona K. Umaretiya PJ, et al. Among authors: flamand y. Pediatr Blood Cancer. 2021 Oct;68(10):e29195. doi: 10.1002/pbc.29195. Epub 2021 Jun 30. Pediatr Blood Cancer. 2021. PMID: 34190405 Free PMC article.
26 results